PharmaCyte Biotech
PMCB
PMCB
21 hedge funds and large institutions have $934K invested in PharmaCyte Biotech in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
78% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 9
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
21
Holding in Top 10
–
Calls
$14K
Puts
$7K
Top Sellers
1 | -$400K | |
2 | -$10.2K | |
3 | -$5.37K | |
4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$5K |
5 |
APC
Aspire Private Capital
Cornelius,
North Carolina
|
-$1.53K |